Alumis ALMS
NASDAQ ALMS
$6.85 -0.36 (-4.99%)
At close: Oct 2, 2026 · 4:00 PM EDT

Alumis (ALMS) Return on Capital Employed [ROCE] (2024 - 2026)

Updated

Alumis' Return on Capital Employed [ROCE] was -122.21% in Q2 2026, up 3.05 percentage points from -125.26% a year earlier.

Analysis

Alumis (ALMS) Return on Capital Employed [ROCE] (2024 - 2026) Analysis & Trends

For FY2025, Return on Capital Employed [ROCE] at Alumis came in at -149.70%, up 33.25 percentage points from FY2024.

  • In earlier years, Return on Capital Employed [ROCE] was -182.95% in FY2024.
  • Quarterly Return on Capital Employed [ROCE] has moved between -147.36% (Q1 2025) and -79.34% (Q3 2024) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Alumis 852.45 Mn -822.39 Mn - -122.21%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -122.21%
Dec 31, 2025 -120.48%
Sep 30, 2025 -94.20%
Jun 30, 2025 -125.26%
Mar 31, 2025 -147.36%
Dec 31, 2024 -92.29%
Sep 30, 2024 -79.34%
API Access

Alumis Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ALMS&period=max&api_key=YOUR_API_KEY